Biotech · Private company

Onyx Therapeutics, Inc.

Track this companyFree. Adds Onyx Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials40 recruiting or active

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Clinical trials4

A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531PHASE2 · COMPLETED · started Apr 1, 2013ClinicalTrials.gov NCT01813227 · fetched Nov 12, 2026
Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple MyelomaPHASE2 · COMPLETED · started Apr 19, 2012ClinicalTrials.gov NCT01559935 · fetched Nov 12, 2026
Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple MyelomaPHASE1_PHASE2 · COMPLETED · started Dec 1, 2011ClinicalTrials.gov NCT01496118 · fetched Nov 12, 2026
Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular CancerPHASE2 · COMPLETED · started Jun 1, 2009ClinicalTrials.gov NCT00813293 · fetched Nov 12, 2026